
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
STDM | Paris | EUR | Real-time | |
DIMp | BATS Europe | EUR | Delayed | |
56S1 | Frankfurt | EUR | Delayed | |
DIM | Vienna | EUR | Real-time |
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiology testing, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; screening instruments; biomolecule analysis tools; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; water purification systems; and weighing products. In addition, the company offers data analytics software; process automation platform and software; and transfection reagents and plasmid DNA solutions. The company has collaboration with Bio Usawa Biotechnology, Ltd. focus on developing and manufacturing monoclonal antibodies in Sub-Saharan Africa to tackle oncology, diabetes-induced eye diseases, infectious diseases, and autoimmune conditions. It serves manufacturers of medications, vaccines, food, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
Name | Age | Since | Title |
---|---|---|---|
Romaine Fernandes | 56 | 2023 | Employee Representative Non - Executive Director |
Cecile Dussart | 60 | 2025 | Independent Director |
Christopher Nowers | - | 2025 | Director |
Lothar Kappich | 68 | 2017 | Director |
Susan Dexter | 70 | 2015 | Independent Director |
Anne-Marie Graffin | 64 | 2015 | Lead Independent Director |
Pascale Boissel | 59 | 2019 | Independent Director |
Rene Faber | 50 | 2019 | CEO & Director |
Michael Grosse | 57 | 2025 | Chairman of the Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review